| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000044695 |
| Receipt No. | R000051051 |
| Scientific Title | Discovery study of biomarkers of small bowel lesion in Crohn's disease by proteome analysis |
| Date of disclosure of the study information | 2021/06/29 |
| Last modified on | 2021/06/29 (Ver. 2) |
| Basic information | ||
| Public title | Discovery study of biomarkers of small bowel lesion in Crohn's disease | |
| Acronym | Biomarkers of small bowel Crohn's disease | |
| Scientific Title | Discovery study of biomarkers of small bowel lesion in Crohn's disease by proteome analysis | |
| Scientific Title:Acronym | ProSBoC study | |
| Region |
|
|
| Condition | ||
| Condition | Crohn's disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | Patients with Crohn's ileitis are often asymptomatic and show no inflammation in blood test. In this study, we performed proteome analysis using plasma in addition to blood markers including CBC, ESR, CRP, LRG, albumin levels, and fecal calprotectin before and 6 months after intensified medical treatment for active Crohn's small bowel lesions. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Improvement of each biomarker 6 months after intensified medical treatment |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | patients with active Crohn's small bowel lesions | |||
| Key exclusion criteria | patients who cannot undergo double-balloon enteroscopy due to bad health condition | |||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Fujita Health University | ||||||
| Division name | Department of advanced Endoscopy | ||||||
| Zip code | 470-1192 | ||||||
| Address | 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, Japan | ||||||
| TEL | 0562-93-9240 | ||||||
| nohmiya@fujita-hu.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Fujita Health University School of Medicine | ||||||
| Division name | IRB | ||||||
| Zip code | 470-1192 | ||||||
| Address | 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, Japan | ||||||
| TEL | 0562-93-2860 | ||||||
| Homepage URL | |||||||
| research@fujita-hu.ac.jp | |||||||
| Sponsor | |
| Institute | Fujita Health University, Department of Advanced Endoscopy, Department of Gastroenterology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Fujita Health University School of Medicine, IRB |
| Address | 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, Japan |
| Tel | 0562-93-2860 |
| research@fujita-hu.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 藤田医科大学病院(愛知県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | |||||||
| Number of participants that the trial has enrolled | 0 | ||||||
| Results | Ongoing | ||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | |||||||
| Participant flow | |||||||
| Adverse events | |||||||
| Outcome measures | |||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | None |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051051 |